# Example Self-Evolving Generated Questions

Sampled from `multi_agent_questions_20260420_101856.jsonl` (594 accepted questions, 8 unique target seeds so far).

Each example shows the generated question, its answer, the retrieval query that surfaced
the grounding passage, and the concatenated passages (top-16 from Milvus) that the generator
synthesized across.

---

## Multiple Choice Examples

### MCQ #1 — target_idx=0

**Reference training question (seed):** Does a dedicated discharge coordinator improve the quality of hospital discharge?

**Retrieval query used:** What is the pathophysiological mechanism by which dedicated discharge coordinators reduce readmission rates in hospitalized patients?

**Generated question:** Which intervention has demonstrated the greatest reduction in 30-day readmission rates across multiple hospital settings according to the provided evidence?

**Options:**

- **A.** A multidisciplinary readmission reduction program with case managers and teach-back methods **[correct]**
- **B.** A patient advocate-driven program that assesses discharge needs on Day 1
- **C.** A care transitions intervention with coaching and provider coordination
- **D.** A dedicated discharge coordinator who calls patients post-discharge

**Correct answer:** A

<details><summary>Retrieved passages (concatenated top-16 from Milvus)</summary>

```
[passage 1 / source=medrag_pubmed]
Bassett Medical Center's multidisciplinary readmission reduction program resulted in a 70% drop in readmissions for high-risk diagnoses at the Cooperstown, NY, facility. Case managers assess all patients for risk of readmission and alert the team when patients are at high risk. Staff members use the teach-back method and have simplified discharge instructions. Case managers and nurses try to identify barriers to follow-up care while the patient is in the hospital. A patient services coordinator calls at-ris

[passage 2 / source=medrag_pubmed]
A readmission reduction program that begins while patients are in the hospital has cut the 30-day readmission rate by 37% at St. Rose Hospital in Hayward, CA. Patient advocates visit patients with diagnoses that put them at risk for readmission on Day 1 and conduct an assessment to determine discharge needs. Advocates collaborate with discharge planners, line up any services needed after discharge, and follow up after discharge and after physician visits. When patients are readmitted, the team drills down t

[passage 3 / source=medrag_pubmed]
Well-executed communication among hospital providers, patients, and receiving providers at the time of hospital discharge contributes to better health outcomes and lower overall health care costs. The Care Transitions Intervention has reduced 30-day hospital readmissions by 30% in a randomized controlled trial in an integrated health system but requires real-world testing to establish effectiveness in other settings. We hypothesized that coaching would reduce 30-day readmission rates for fee-for-service Med
```

</details>

---

### MCQ #2 — target_idx=1

**Reference training question (seed):** Does the National Institutes of Health Stroke Scale favor left hemisphere strokes?

**Retrieval query used:** What is the pathophysiological basis for the NIH Stroke Scale's differential weighting of left versus right hemisphere stroke deficits?

**Generated question:** In patients with right hemisphere stroke, how might the NIHSS scoring system impact clinical trial eligibility if a low score is used as an exclusion criterion?

**Options:**

- **A.** The NIHSS may underrepresent right hemisphere deficits, leading to under-enrollment of these patients. **[correct]**
- **B.** The NIHSS is equally sensitive to both hemispheres and does not favor one side.
- **C.** The NIHSS penalizes right hemisphere strokes more heavily due to greater motor impairment.
- **D.** Right hemisphere strokes are always excluded because they have higher NIHSS scores than left hemisphere strokes.

**Correct answer:** A

<details><summary>Retrieved passages (concatenated top-16 from Milvus)</summary>

```
[passage 1 / source=medrag_pubmed]
The National Institutes of Health Stroke Scale (NIHSS) is an established measure of neurological impairment; however, it can award more points for tests of presumed left-hemisphere function, such as language, than for tests of right-hemisphere function, such as neglect. This difference may be important if a low NIHSS score is used to exclude patients with right-hemisphere stroke from clinical trials or established treatments. The aim of this study was to investigate whether the relationship between acute NI

[passage 2 / source=mirage]
Does the National Institutes of Health Stroke Scale favor left hemisphere strokes? Answer: A

[passage 3 / source=medrag_pubmed]
The National Institutes of Health Stroke Scale (NIHSS) is a valid, reproducible scale that measures neurological deficit. Of 42 possible points, 7 points are directly related to measurement of language compared with only 2 points related to neglect. We examined the placebo arm of the NINDS t-PA stroke trial to test the hypothesis that the total volume of cerebral infarction in patients with right hemisphere strokes would be greater than the volume of cerebral infarction in patients with left hemisphere stro
```

</details>

---

### MCQ #3 — target_idx=2

**Reference training question (seed):** Is a pressor necessary during aortic perfusion and oxygenation therapy of cardiac arrest?

**Retrieval query used:** What is the pathophysiological rationale for using vasopressors during aortic perfusion and oxygenation in cardiac arrest patients?

**Generated question:** In a patient undergoing aortic balloon occlusion during CPR, which strategy is most likely to enhance myocardial perfusion while minimizing adverse effects on cerebral blood flow, based on hemodynamic principles and pharmacologic profiles?

**Options:**

- **A.** Intravenous vasopressin administration
- **B.** Intra-aortic vasopressin delivery above the balloon occlusion **[correct]**
- **C.** Nitroglycerin infusion to reduce afterload
- **D.** High-dose epinephrine to increase contractility

**Correct answer:** B

<details><summary>Retrieved passages (concatenated top-16 from Milvus)</summary>

```
[passage 1 / source=medrag_pubmed]
The outcome for both in-hospital and out-of hospital cardiac arrest remains dismal. Vasopressors are used to increase coronary perfusion pressure and thus facilitate return of spontaneous circulation during cardiopulmonary resuscitation. However, they are associated with a number of potential adverse effects and may decrease endocardial and cerebral organ blood flow. Nitroglycerin has a favourable haemodynamic profile which promotes forward blood flow. Several studies suggest that combined use of nitroglyce

[passage 2 / source=medrag_pubmed]
Intravenous administration of vasopressin during cardiopulmonary resuscitation (CPR) has been shown to improve myocardial and cerebral blood flow. Aortic balloon occlusion during CPR may also augment myocardial and cerebral blood flow and can be used as a central route for the administration of resuscitative drugs. We hypothesized that, as compared with intravenously administered vasopressin, the administration of this drug above the site of an aortic balloon occlusion would result in a greater increase in 

[passage 3 / source=medrag_pubmed]
Intervention for cardiac arrest may require intervention for electrical abnormalities or hemodynamic instability. These actions can result in ineffective cardiac functioning and systemic hypotension. Vasopressors are capable of improving severe hypotension that can result from reduced cardiovascular contractility or heart rate. These vasopressor actions are critical to successful resuscitation efforts for patients.
```

</details>

---

### MCQ #4 — target_idx=3

**Reference training question (seed):** The nurse cystoscopist: a feasible option?

**Retrieval query used:** What is the molecular and cellular mechanism underlying the development of bladder tumors and how does cystoscopy facilitate early detection?

**Generated question:** In patients with recurrent bladder cancer, which of the following best describes the clinical context where cystoscopy may be considered less optimal despite being the gold standard for detection?

**Options:**

- **A.** When patient discomfort and cost are primary concerns in a low-risk surveillance setting **[correct]**
- **B.** When early-stage tumors are reliably detected via noninvasive urine biomarkers
- **C.** When urethral stricture or bladder mucosal changes preclude visual inspection
- **D.** When cytology results are negative but clinical suspicion remains high

**Correct answer:** A

<details><summary>Retrieved passages (concatenated top-16 from Milvus)</summary>

```
[passage 1 / source=medrag_pubmed]
Cystoscopy is the principal method in the diagnosis of bladder cancer and precancer, but though visual examination of the bladder cavity via a cystoscope is comparatively easy, early correct diagnosis is not always possible because of small volume of the bladder, urethral stricture, mucosal changes in the bladder. That is why so much attention is paid to the cytologic diagnosis of bladder conditions. To estimate the diagnostic value of the cytologic method for the recognition of bladder precancer states and

[passage 2 / source=medrag_pubmed]
Bladder cancer is a common disease that causes significant morbidity and mortality in the United States. Early detection and routine surveillance are recommended in the management of this chronic and recurrent disease. Cystoscopic examination has been used for detection and follow-up; however, it is costly and is associated with patient discomfort. With advances in molecular biology and biochemistry, many diagnostic assays have been developed to supplement cystoscopy. The mechanisms and variable results of 

[passage 3 / source=medrag_pubmed]
Bladder cancer is one of the most prevalent cancers worldwide. Early detection of bladder tumors is critical for improved patient outcomes. The standard method for detection and surveillance of bladder tumors is cystoscopy with urinary cytology. Limitations of cystoscopy and urinary cytology have brought to light the need for more robust diagnostic assays. Ideally, such assays would be applicable to noninvasively obtained, voided urine, and be designed not only for diagnosis, but also for monitoring disease
```

</details>

---

## Free-Response Examples

### Free #1 — target_idx=0

**Reference training question (seed):** Does a dedicated discharge coordinator improve the quality of hospital discharge?

**Retrieval query used:** What diagnostic criteria or validated metrics are used to assess the effectiveness of discharge coordination on patient outcomes?

**Generated question:** In a randomized trial evaluating a dedicated discharge coordinator, what outcome was most consistently improved in patients interviewed pre- and post-discharge?

**Expected answer:** reduced unplanned readmission

<details><summary>Retrieved passages (concatenated top-16 from Milvus)</summary>

```
[passage 1 / source=medrag_pubmed]
To evaluate the effectiveness of the role of a discharge coordinator whose sole responsibility was to plan and coordinate the discharge of patients from medical wards. An intervention study in which the quality of discharge planning was assessed before and after the introduction of a discharge coordinator. Patients were interviewed on the ward before discharge and seven to 10 days after being discharged home. The three medical wards at the Homerton Hospital in Hackney, East London. 600 randomly sampled adul

[passage 2 / source=medrag_pubmed]
Discharge planning is a routine feature of health systems in many countries. The aim of discharge planning is to reduce hospital length of stay and unplanned readmission to hospital, and improve the co-ordination of services following discharge from hospital. To determine the effectiveness of planning the discharge of patients moving from hospital. We updated the review using the Cochrane EPOC Group Trials Register, MEDLINE, EMBASE and the Social Science Citation Index (last searched in March 2009). Randomi

[passage 3 / source=mirage]
Does a dedicated discharge coordinator improve the quality of hospital discharge? Answer: A
```

</details>

---

### Free #2 — target_idx=1

**Reference training question (seed):** Does the National Institutes of Health Stroke Scale favor left hemisphere strokes?

**Retrieval query used:** Are there known complications or misinterpretations associated with using the NIH Stroke Scale in left hemisphere stroke patients?

**Generated question:** Which hemispheric stroke is more likely to be underestimated by NIHSS due to its bias toward dominant hemisphere functions?

**Expected answer:** non-dominant hemisphere stroke

<details><summary>Retrieved passages (concatenated top-16 from Milvus)</summary>

```
[passage 1 / source=medrag_pubmed]
The National Institutes of Health Stroke Scale (NIHSS) is an established measure of neurological impairment; however, it can award more points for tests of presumed left-hemisphere function, such as language, than for tests of right-hemisphere function, such as neglect. This difference may be important if a low NIHSS score is used to exclude patients with right-hemisphere stroke from clinical trials or established treatments. The aim of this study was to investigate whether the relationship between acute NI

[passage 2 / source=mirage]
Does the National Institutes of Health Stroke Scale favor left hemisphere strokes? Answer: A

[passage 3 / source=medrag_pubmed]
The National Institutes of Health Stroke Scale (NIHSS) has been criticized for limited representation of cognitive dysfunction and bias towards dominant hemisphere functions. Patients may therefore receive a low NIHSS score despite a fairly large stroke. A broader scale including simple cognitive tests would improve the clinical and research utility of the NIHSS. We studied 200 patients with acute non-dominant hemispheric stroke who underwent cognitive testing and had MRI with diffusion-weighted imaging (DW
```

</details>

---

### Free #3 — target_idx=2

**Reference training question (seed):** Is a pressor necessary during aortic perfusion and oxygenation therapy of cardiac arrest?

**Retrieval query used:** What diagnostic criteria or hemodynamic thresholds determine the need for vasopressor support during aortic perfusion and oxygenation in cardiac arrest?

**Generated question:** What is the recommended vasopressor agent and dosing for optimizing coronary and cerebral perfusion during advanced cardiac life support in adults?

**Expected answer:** epinephrine 1 mg every 5 minutes

<details><summary>Retrieved passages (concatenated top-16 from Milvus)</summary>

```
[passage 1 / source=medrag_textbook]
fluid administration; a diuretic such as furosemide may be used if needed. In about one-third of patients, hypotension and organ hypoperfusion respond to fluid resuscitation; a reasonable goal is to maintain a mean arterial blood pressure of >65 mmHg (systolic pressure >90 mmHg). If these guidelines cannot be met by volume infusion, vasopressor therapy is indicated (Chap. 326). Titrated doses of norepinephrine should be administered through a central catheter. If myocardial dysfunction produces elevated car

[passage 2 / source=medrag_pubmed]
Survival after hypovolemic shock and cardiac arrest is dismal with current therapies. We evaluated the potential benefits of vasopressin versus large-dose epinephrine in hemorrhagic shock and cardiac arrest on vital organ perfusion, and the likelihood of resuscitation. In 18 pigs, 35% of the estimated blood volume was withdrawn over 15 min and ventricular fibrillation was induced 5 min later. After 4 min of cardiac arrest and 4 min of standard cardiopulmonary resuscitation, a bolus dose of either 200 microg

[passage 3 / source=medrag_pubmed]
Optimal vasopressor support during resuscitation should theoretically enhance aortic diastolic and coronary perfusion pressure as well as coronary and cerebral blood flow/oxygen delivery without increasing cellular oxygen demand. Intravenous vasopressor support, using 1 mg doses of epinephrine every 5 minutes in adults or vasopressin 40 IU, is recommended by American Heart Association Advanced Cardiac Life Support Guidelines to maximize oxygen delivery to the heart and brain and increase cellular high energ
```

</details>

---

### Free #4 — target_idx=3

**Reference training question (seed):** The nurse cystoscopist: a feasible option?

**Retrieval query used:** What diagnostic criteria or imaging thresholds are used to differentiate non-muscle-invasive bladder cancer from muscle-invasive disease during cystoscopy?

**Generated question:** In non-muscle-invasive bladder cancer, what is the most significant limitation of conventional white-light cystoscopy that impacts surgical outcomes?

**Expected answer:** Difficulty assessing surgical margin negativity

<details><summary>Retrieved passages (concatenated top-16 from Milvus)</summary>

```
[passage 1 / source=medrag_pubmed]
In total, 70-80% of newly diagnosed bladder cancers are confined to the mucosa and staged as Ta, T1 or carcinoma in situ according to the 2002 tumor, lymph nodes and metastasis classification. The standard treatment for these nonmuscle-invasive bladder cancers is transurethral tumor resection with or without adjuvant intravesical chemotherapy or intravesical immunotherapy and subsequent follow-up. Diagnosis and follow-up of nonmuscle-invasive bladder cancer offers two main problems. First, approximately 10-

[passage 2 / source=medrag_pubmed]
At the time of diagnosis, approximately 75% of bladder cancers are non-muscle invasive. Appropriate diagnosis and surgical resection at this stage improves prognosis dramatically. However, these lesions, being small and/or flat, are often missed by conventional white-light cystoscopes. Furthermore, it is difficult to assess the surgical margin for negativity using conventional cystoscopes. Resultantly, the recurrence rates in patients with early bladder cancer are very high. This is currently addressed by r

[passage 3 / source=medrag_pubmed]
To review the diagnosis and management of all stages of bladder cancer with an emphasis on studies and developments within the last year. Cystoscopy remains the gold standard for diagnosis of bladder tumors, though fluorescent light and urinary biomarkers can both improve the sensitivity of cancer detection. Management of high-risk patients with nonmuscle invasive cancer continues to be controversial, with a number of risk assessment tools developed to help stratify patients to cystectomy or bladder-sparing
```

</details>

---

